RUS
Details
| Name | PROTEK |
| Placement specification | common stock |
| Placement type | IPO |
| Subscription type | Public offering |
| Start of placement | 14.04.2010 |
| Status | Completed |
| End of placement | 26.04.2010 |
| Placement amount | 114 285 714 |
| Placement volume, mln. USD | 400 |
| Upper bound, USD | 4.50 |
| Lower bound, USD | 3.10 |
| Offering price, USD | 3.50 |
| Price change from the placement date | -67.66% |
| Trading floor | MICEX, RTS |
| Investment banks | Renaissance Capital, UBS Investment Bank |
| Capitalisation at the moment of placement, mln. USD | 2 200 |
| Country of operation | Russia |
| Industry | Pharmaceutical industry |
| Offering Memorandum |
Issuer
“PROTEK” is one of the largest pharmaceutical companies in Russia. The company has a diversified business structure, it operates in all pharmaceutical sectors: production of medications, distribution of health and beauty products and retail sales.
Web-site: to the issuer site
Issuer news
-
25.10.2010
Investfunds: RMG Research: Protek: Weak in 2010, but Still Undervalued
-
13.07.2010
Investfunds: RMG Research: Protek: Large Business, Little Upside
Stock details
| Stock | Protek |
| Type | common stock |
| Par value, RUB | 0.01 |
| State registration number | 1-02-07615-A |
| ISIN | RU000A0JQU47 |
| Announced volume | 527 142 857 |
| Free-float | 0.17 |
MICEX
Ticker:
PRTK
Quotation list:
Unlisted stocks
RTS
Ticker:
PRTK
Quotation list:
Unlisted stocks
Price dynamics
| MICEX | RTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||